Long Term Complete Response of Unresectable Locally Advanced Pancreatic Cancer after CCRT and Gemcitabine Chemotherapy.
10.15279/kpba.2016.21.4.209
- Author:
Jaeyun YANG
1
;
Taekyu LIM
;
Taegyoon KIM
;
Seungmoon HAN
;
Sanghee LEE
;
Huiseo KIM
;
Jiwon LEE
;
Seongyeong AHN
Author Information
1. Department of Internal Medicine, Veterans Health Service Medical Center, Seoul, Korea. imegene@naver.com
- Publication Type:Case Report
- Keywords:
Pancreatic cancer;
Chemoradiotherapy;
Gemcitabine;
Chemotherapy
- MeSH:
Adenocarcinoma;
Chemoradiotherapy;
Drug Therapy*;
Humans;
Maintenance Chemotherapy;
Pancreatic Neoplasms*;
Radiotherapy
- From:Korean Journal of Pancreas and Biliary Tract
2016;21(4):209-215
- CountryRepublic of Korea
- Language:English
-
Abstract:
Locally advanced or metastatic disease accounts for two thirds of total patients with pancreatic cancer. Patients with pancreatic cancer are assessed as resectable, potentially resectable (borderline) or unresectable according to pre-operative examinations. The chances of resectability may be enhanced by using neoadjuvant systemic chemotherapy, radiotherapy or both. This case report presents a locally advanced pancreatic adenocarcinoma that was identified to be unresectable during surgical exploration. After receiving concurrent chemoradiotherapy, the patient was re-evaluated, identified as unresectable and received gemcitabine maintenance chemotherapy. Herein, we report the case of a patient with unresectable locally advanced pancreatic adenocarcinoma who achieved a complete response lasting for more than 32 months after receiving concurrent chmoradiotherapy followed by gemcitabine maintenance chemotherapy.
